Related references
Note: Only part of the references are listed.Review article: rifabutin in the treatment of refractory Helicobacter pylori infection
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Guidelines for treatment of Helicobacter pylori in the East and West
Michael Selgrad et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Rescue therapy after Helicobacter pylori eradication failure
Javier P. Gisbert
GASTROENTEROLOGIA Y HEPATOLOGIA (2011)
Second-line Helicobacter pylori Eradication: A Randomized Comparison of 1-week or 2-week Bismuth-containing Quadruple Therapy
Jun-Won Chung et al.
HELICOBACTER (2011)
Treatment of Helicobacter pylori Infection 2011
Anthony O'Connor et al.
HELICOBACTER (2011)
Key Points for Designing and Reporting Helicobacter pylori Therapeutic Trials: A Personal View
Xavier Calvet et al.
HELICOBACTER (2011)
Efficacy of 2-Week, Second-Line Helicobacter pylori Eradication Therapy Using Rabeprazole, Amoxicillin, and Metronidazole for the Japanese Population
Kazutoshi Hori et al.
HELICOBACTER (2011)
Mutations of Helicobacter pylori Associated with Fluoroquinolone Resistance in Korea
Jung W. Lee et al.
HELICOBACTER (2011)
Resistance of Helicobacter pylori to quinolones and clarithromycin assessed by genetic testing in Japan
Mihoko Yamade et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
Peter Malfertheiner et al.
LANCET (2011)
HELICOBACTER PYLORI ERADICATION A new, single-capsule bismuth-containing quadruple therapy
Javier P. Gisbert
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Helicobacter pylori Infection A Randomized, Controlled Study Comparing 2 Rescue Therapies After Failure of Standard Triple Therapies
Deng-Chyang Wu et al.
MEDICINE (2011)
Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland
Elzbieta Karczewska et al.
PHARMACOLOGICAL REPORTS (2011)
Second-Line Levofloxacin-Based Triple Therapy's Efficiency for Helicobacter pylori Eradication in Patients With Peptic Ulcer
Fatih Ermis et al.
SOUTHERN MEDICAL JOURNAL (2011)
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area
J. Yakoob et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2010)
Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents
Lyudmila Boyanova et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)
Helicobacter pylori treatment in the era of increasing antibiotic resistance
David Y. Graham et al.
GUT (2010)
A Randomized Controlled Trial: Efficacy and Safety of Azithromycin, Ofloxacin, Bismuth, and Omeprazole Compared With Amoxicillin, Clarithromycin, Bismuth, and Omeprazole as Second-Line Therapy in Patients With Helicobacter pylori Infection
Mohammad Minakari et al.
HELICOBACTER (2010)
Bismuth-Containing Quadruple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea
Byoung Hwan Lee et al.
HELICOBACTER (2010)
Treatment of Helicobacter pylori Infection 2010
Anthony O'Connor et al.
HELICOBACTER (2010)
High Efficacy of 14-Day Triple Therapy-Based, Bismuth-Containing Quadruple Therapy for Initial Helicobacter pylori Eradication
Qinjuan Sun et al.
HELICOBACTER (2010)
The Evolution of Helicobacter pylori Antibiotics Resistance Over 10 Years in Beijing, China
Wen Gao et al.
HELICOBACTER (2010)
High Level of Antimicrobial Resistance in French Helicobacter pylori Isolates
Josette Raymond et al.
HELICOBACTER (2010)
Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study
L. -W. Chen et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Sequential Therapy for Helicobacter pylori Infection: Ethical Considerations Revisited
David Y. Graham et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Sequential Therapy for Helicobacter pylori Eradication A Critical Review
Javier P. Gisbert et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Comparison of 7-and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia
Cemal Nuri Ercin et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2010)
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis
Yuqin Li et al.
WIENER KLINISCHE WOCHENSCHRIFT (2010)
Cumulative H-pylori Eradication Rates in Clinical Practice by Adopting First and Second-Line Regimens Proposed by the Maastricht III Consensus and a Third-Line Empirical Regimen
Theodore Rokkas et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
H-pylori Treatment: New Wine in Old Bottles?
Nimish Vakil
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication
Jaime N. Eisig et al.
BMC GASTROENTEROLOGY (2009)
Efficient Identification and Evaluation of Effective Helicobacter pylori Therapies
David Y. Graham
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication
S. Di Caro et al.
DIGESTIVE AND LIVER DISEASE (2009)
Prevalence of Primary Fluoroquinolone Resistance Among Clinical Isolates of Helicobacter pylori at a University Hospital in Southern Taiwan
Kuei-Hsiang Hung et al.
HELICOBACTER (2009)
Impact of Quadruple Regimen of Clarithromycin Added to Metronidazole-Containing Triple Therapy Against Helicobacter pylori Infection Following Clarithromycin-Containing Triple-Therapy Failure
Nobue Ueki et al.
HELICOBACTER (2009)
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial
Chao-Hung Kuo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan
Wei-Lun Chang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK
Stephanie A. Chisholm et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Second-line rescue therapy with levofloxacin after H-Pylori treatment failure: A Spanish multicenter study of 300 patients
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Persistent Helicobacter pylori Infection After a Course of Antimicrobial Therapy-What's Next?
Richard J. Saad et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Treatment of Helicobacter pylori infection
Brian J. Egan et al.
HELICOBACTER (2008)
Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection
Kazunari Murakami et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates
M. Romano et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Comparison of short- and long-term treatment protocols and the results of second-line quadruple therapy in children with Helicobacter pylori infection
Yusuf Usta et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Rescue regimens after Helicobacter pylori treatment failure
Javier P. Gisbert
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Empirical rescue therapy after Helicobacter pylori treatment failure:: a 10-year single-centre study of 500 patients
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy
Ahmet Uygun et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
An alternative salvage regimen for Helicobacter pylori-resistant patients with heart failure
Robert Lee Page et al.
CARDIOLOGY (2008)
Levofloxacin-based triple therapy for Helicobacter pylori re-treatment:: Role of bacterial resistance
F. Perna et al.
DIGESTIVE AND LIVER DISEASE (2007)
Helicobacter pylori and antibiotic resistance
Francis Megraud
GUT (2007)
Evolution of Helicobacter pylori therapy from a meta-analytical perspective
Javier P. Gisbert et al.
HELICOBACTER (2007)
Levofloxacin in first-line treatment of Helicobacter pylori infection
A. Rispo et al.
HELICOBACTER (2007)
First-line triple therapy with levofloxacin for Helicobacter pylori eradication
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection
Jose M. Navarro-Jarabo et al.
BMC GASTROENTEROLOGY (2007)
Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy
A. Zullo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Current concepts in the management of Helicobacter pylori infection:: the maastricht III consensus report
P. Malfertheiner et al.
GUT (2007)
Update on fluoroquinolone resistance in Helicobacter pylori:: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility
Vincent Cattoir et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection
John J. Carothers et al.
CLINICAL INFECTIOUS DISEASES (2007)
Quinolone resistance in Helicobacter pylori isolates in Germany
Erik Glocker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
How to proceed in Helicobacter pylori-positive chronic gastritis refractory to first- and second-line eradication therapy
Dino Vaira et al.
DIGESTIVE DISEASES (2007)
Susceptibility-guided vs. empiric retreatment of Helicobacter pylori infection after treatment failure
Jacob Yahav et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Randomized comparison of two rescue therapies for Helicobacter pylori infection
D. C. Wu et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium
Pierre Bogaerts et al.
HELICOBACTER (2006)
Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection
Kazunari Murakami et al.
HELICOBACTER (2006)
A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures
Yi-Chia Lee et al.
HELICOBACTER (2006)
Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan
Hideyuki Miyachi et al.
HELICOBACTER (2006)
Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole
Leonardo Marzio et al.
HELICOBACTER (2006)
Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin
S. Miehlke et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients
Jung Mogg Kim et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
In vitro activity of levofloxacin against Helicobacter pylori isolates from patients after treatment failure
Jacob Yahav et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection:: A meta-analysis
RJ Saad et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection
WM Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity
D Antos et al.
HELICOBACTER (2006)
A study of 4-and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication
EG Giannini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Levofloxacin-versus metronidazole-based rescue therapy for H-pylori infection in Japan
Y Matsumoto et al.
DIGESTIVE AND LIVER DISEASE (2005)
Helicobacter pylori rescue therapy after failure of two eradication treatments
JP Gisbert et al.
HELICOBACTER (2005)
A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses
L Gatta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures:: a pilot study
LGV Coelho et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Comparison of two management strategies for Helicobacter pylori treatment: Clinical study and cost-effectiveness analysis
D Marko et al.
HELICOBACTER (2005)
High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication
G Cammarota et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
H pylori antibiotic resistance:: prevalence, importance, and advances in testing
F Mégraud
GUT (2004)
A 10-Day Levofloxacin-Based Therapy in Patients With Resistant Helicobacter pylori Infection: A Controlled Trial
Claudio Bilardi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Second-line treatment for Helicobacter pylori infection in Japan:: proton pump inhibitor-based amoxicillin and metronidazole regimen
A Nagahara et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population
T Shimoyama et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'
F Perri et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Second-line treatment for failure to eradicate Helicobacter pylori:: a randomized trial comparing four treatment strategies
H Lamouliatte et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy
Y Watanabe et al.
DIGESTIVE AND LIVER DISEASE (2003)
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment:: a randomized trial
EC Nista et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts
F Parente et al.
DIGESTIVE AND LIVER DISEASE (2003)
High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection
H Isomoto et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?
H Miwa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection
WM Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Levofloxacin - A review of its use in the treatment of bacterial infections in the United States
KF Croom et al.
DRUGS (2003)
Levofloxacin based regimens for the eradication of Helicobacter pylori
S Di Caro et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori
M Tanaka et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Helicobacter pylori 'rescue' regimen when proton pump inhibitor-based triple therapies fail
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection:: impact of two second-line therapies in a randomized study
U Peitz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Current concepts in the management of Helicobacter pylori infection -: The Maastricht 2-2000 Consensus Report
P Malfertheiner et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection
A Nagahara et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Therapeutic strategies in Helicobacter pylori infection
X Calvet et al.
MEDICINA CLINICA (2001)
A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy
N Magaret et al.
DIGESTIVE DISEASES (2001)
Latest industry information on the safety profile of levofloxacin in the US
JB Kahn
CHEMOTHERAPY (2001)
Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999)
J Cabrita et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy
B Sicilia et al.
MEDICINA CLINICA (2000)
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies:: a prospective study
A Pilotto et al.
DIGESTIVE AND LIVER DISEASE (2000)
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection
G Cammarota et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole:: a meta-analysis of eradication of Helicobacter pylori
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones
JEG Sánchez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Helicobacter pylori eradication therapy.: The Spanish Consensus Report
JP Gisbert et al.
MEDICINA CLINICA (2000)
Regular review - Treatment of Helicobacter pylori infection
WA de Boer et al.
BRITISH MEDICAL JOURNAL (2000)
Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy - A meta-analytical approach
MP Dore et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
Share Paper
